Doctors have warned users of medicines such as Ozempic Wegovy and Mounjaro about an irreversible potential side effect ...

Legal battle over semaglutide between Novo Nordisk and Indian drugmakers will set precedent for future opportunities and ...

According to leaders in obesity and nutrition research, following these key nutrition guidelines will make the most of GLP-1 ...

Wegovy and other GLP-1 obesity and blood sugar control drugs accounted for 17% of pharmacy benefits spending at CBIZ employer ...

Women taking oral hormone replacement therapy are being advised to talk to their doctor if they also start using Mounjaro, ...

Humans have spent thousands of years experimenting with weight loss aids. While Ozempic and Wegovy may be generating ...

A mother has revealed how she lost nine stone in just 12 months without resorting to weight loss jabs or surgery—instead ...

It was just from eating in a calorie deficit but I tried to educate myself on the scientific way of losing weight healthily'. Then, in January 2024, Ms Crabtree committed herself to preparing for a ...

The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...

Novo Nordisk's semaglutide product to lose patent protection in China next year, according to L.E.K. Consulting Competition in the mainland Chinese market for diabetes and weight loss drugs is set to ...

Are you tired of boring dieting and gruesome workouts? Then, medical weight loss treatment can be a solution for you. But ...

The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and ...